MedOne

MedOne is an independent pharmacy benefit manager focused on delivering transparency, flexibility, and control over pharmacy spend for self-funded employers. The Company’s flat, per-member administrative fee and 100% pass-through model eliminates the spread-based pricing and rebate-driven conflicts typical of traditional PBM models, aligning MedOne’s incentives with reduced total drug spend. Through its in-house clinical infrastructure and proprietary technology, MedOne consistently delivers lower pharmacy costs, improved clinical outcomes, and high member satisfaction across a growing national client base. Pamlico invested in MedOne in 2026.